Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress

Nucleic Acids Research

Volumn 42, Issue 3, 2014, Pages 1799-1811

  Bai, Dongmei ^a   Zhang, Jinfang ^a   Xiao, Weichun ^a   Zheng, Xiaofeng ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL LINE; CELL PROLIFERATION; HUMANS; MICE; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84894236850     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt971     Document Type: Article

References (52)

1. Vogelstein, B., Lane, D. and Levine, A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
2. Zhang, Y., Wang, J., Yuan, Y., Zhang, W., Guan, W., Wu, Z., Jin, C., Chen, H., Zhang, L., Yang, X. et al. (2010) Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res., 38, 6544-6554.
3. Zhu, Y., Poyurovsky, M.V., Li, Y., Biderman, L., Stahl, J., Jacq, X. and Prives, C. (2009) Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol. Cell, 35, 316-326.
4. Barak, Y., Juven, T., Haffner, R. and Oren, M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J., 12, 461-468.
5. Wu, X., Bayle, J.H., Olson, D. and Levine, A.J. (1993) The p53- mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132.
6. Lahav, G., Rosenfeld, N., Sigal, A., Geva-Zatorsky, N., Levine, A.J., Elowitz, M.B. and Alon, U. (2004) Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat. Genet., 36, 147-150.
7. Bhat, K.P., Itahana, K., Jin, A. and Zhang, Y. (2004) Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J., 23, 2402-2412.
8. Zhang, Y. and Lu, H. (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell, 16, 369-377.
9. Fumagalli, S., Di Cara, A., Neb-Gulati, A., Natt, F., Schwemberger, S., Hall, J., Babcock, G.F., Bernardi, R., Pandolfi, P.P. and Thomas, G. (2009) Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell. Biol., 11, 501-508.
10. Montanaro, L., Trere, D. and Derenzini, M. (2008) Nucleolus, ribosomes, and cancer. Am. J. Pathol., 173, 301-310.
11. Fumagalli, S., Ivanenkov, V.V., Teng, T. and Thomas, G. (2012) Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev., 26, 1028-1040.
12. Narla, A. and Ebert, B.L. (2010) Ribosomopathies: human disorders of ribosome dysfunction. Blood, 115, 3196-3205.
13. Shenoy, N., Kessel, R., Bhagat, T., Bhattacharya, S., Yu, Y., McMahon, C. and Verma, A. (2012) Alterations in the ribosomal machinery in cancer and hematologic disorders. J. Hematol. Oncol., 5, 32.
14. Ito, E., Konno, Y., Toki, T. and Terui, K. (2010) Molecular pathogenesis in Diamond-Blackfan anemia. Int. J. Hematol., 92, 413-418.
15. Boria, I., Garelli, E., Gazda, H.T., Aspesi, A., Quarello, P., Pavesi, E., Ferrante, D., Meerpohl, J.J., Kartal, M., Da Costa, L. et al. (2010) The ribosomal basis of diamond-blackfan anemia: mutation and database update. Hum. Mutat., 31, 1269-1279.
16. Barlow, J.L., Drynan, L.F., Trim, N.L., Erber, W.N., Warren, A.J. and McKenzie, A.N. (2010) New insights into 5q- syndrome as a ribosomopathy. Cell Cycle, 9, 4286-4293.
17. Boultwood, J., Pellagatti, A., McKenzie, A.N. and Wainscoat, J.S. (2010) Advances in the 5q- syndrome. Blood, 116, 5803-5811.
18. Deisenroth, C. and Zhang, Y. (2010) Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene, 29, 4253-4260.
19. Zhou, X., Hao, Q., Liao, J., Zhang, Q. and Lu, H. (2012) Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene, 32, 388-396.
20. Miliani de Marval, P.L. and Zhang, Y. (2011) The RP-Mdm2-p53 pathway and tumorigenesis. Oncotarget, 2, 234-238.
21. Ashcroft, M., Taya, Y. and Vousden, K.H. (2000) Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol., 20, 3224-3233.
22. Dai, M.S. and Lu, H. (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem., 279, 44475-44482.
23. Lohrum, M.A., Ludwig, R.L., Kubbutat, M.H., Hanlon, M. and Vousden, K.H. (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell, 3, 577-587.
24. Sasaki, M., Kawahara, K., Nishio, M., Mimori, K., Kogo, R., Hamada, K., Itoh, B., Wang, J., Komatsu, Y., Yang, Y.R. et al. (2011) Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat. Med., 17, 944-951.
25. Zhang, Y., Wolf, G.W., Bhat, K., Jin, A., Allio, T., Burkhart, W.A. and Xiong, Y. (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomalstress checkpoint pathway. Mol. Cell. Biol., 23, 8902-8912.
26. Chen, D., Zhang, Z., Li, M., Wang, W., Li, Y., Rayburn, E.R., Hill, D.L., Wang, H. and Zhang, R. (2007) Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene, 26, 5029-5037.
27. Zhang, J., Bai, D., Ma, X., Guan, J. and Zheng, X. (2012) hCINAP is a novel regulator of ribosomal protein-HDM2-p53 pathway by controlling NEDDylation of ribosomal protein S14. Oncogene, 33, 246-254.
28. Lindstrom, M.S., Deisenroth, C. and Zhang, Y. (2007) Putting a finger on growth surveillance: insight into MDM2 zinc fingerribosomal protein interactions. Cell Cycle, 6, 434-437.
29. Dai, M.S., Zeng, S.X., Jin, Y., Sun, X.X., David, L. and Lu, H. (2004) Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol., 24, 7654-7668.
30. Macias, E., Jin, A., Deisenroth, C., Bhat, K., Mao, H., Lindstrom, M.S. and Zhang, Y. (2010) An ARF-independent c- MYC-Activated tumor suppression pathway mediated by ribosomal protein-Mdm2 interaction. Cancer Cell, 18, 231-243.
31. Kenmochi, N., Yoshihama, M., Higa, S. and Tanaka, T. (2000) The human ribosomal protein L6 gene in a critical region for Noonan syndrome. J. Hum. Genet., 45, 290-293.
32. Ion, A., Crosby, A.H., Kremer, H., Kenmochi, N., Van Reen, M., Fenske, C., Van Der Burgt, I., Brunner, H.G., Montgomery, K., Kucherlapati, R.S. et al. (2000) Detailed mapping, mutation analysis, and intragenic polymorphism identification in candidate Noonan syndrome genes MYL2, DCN, EPS8, and RPL6. J. Med. Genet., 37, 884-886.
33. Gou, Y., Shi, Y., Zhang, Y., Nie, Y., Wang, J., Song, J., Jin, H., He, L., Gao, L., Qiao, L. et al. (2010) Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells. Biochem. Biophys. Res. Commun, 393, 788-793.
34. Du, J.P., Jin, X.H., Shi, Y.Q., Cao, Y.X., Zhao, Y.Q., Liu, C.J., Yin, F., Hu, W.H., Chen, B.J., Qiao, T.D. et al. (2003) [Differential expression of RPL6/Taxreb107 in drug resistant gastric cancer cell line SGC7901/ADR and its correlation with multiple-drug resistance]. Zhonghua Zhong Liu Za Zhi, 25, 21-25.
35. Gilkes, D.M., Chen, L. and Chen, J. (2006) MDMX regulation of p53 response to ribosomal stress. EMBO J., 25, 5614-5625.
36. Gilkes, D.M. and Chen, J. (2007) Distinct roles of MDMX in the regulation of p53 response to ribosomal stress. Cell Cycle, 6, 151-155.
37. Ofir-Rosenfeld, Y., Boggs, K., Michael, D., Kastan, M.B. and Oren, M. (2008) Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol. Cell, 32, 180-189.
38. He, H. and Sun, Y. (2007) Ribosomal protein S27L is a direct p53 target that regulates apoptosis. Oncogene, 26, 2707-2716.
39. Dai, M.S., Shi, D., Jin, Y., Sun, X.X., Zhang, Y., Grossman, S.R. and Lu, H. (2006) Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J. Biol. Chem., 281, 24304-24313.
40. Jin, A., Itahana, K., O'Keefe, K. and Zhang, Y. (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol., 24, 7669-7680.
41. Jones, N.C., Lynn, M.L., Gaudenz, K., Sakai, D., Aoto, K., Rey, J.P., Glynn, E.F., Ellington, L., Du, C., Dixon, J. et al. (2008) Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med., 14, 125-133.
42. Ruggero, D. and Pandolfi, P.P. (2003) Does the ribosome translate cancer? Nat. Rev. Cancer, 3, 179-192.
43. Ebert, B.L., Pretz, J., Bosco, J., Chang, C.Y., Tamayo, P., Galili, N., Raza, A., Root, D.E., Attar, E., Ellis, S.R. et al. (2008) Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature, 451, 335-339.
44. Takagi, M., Absalon, M.J., McLure, K.G. and Kastan, M.B. (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell, 123, 49-63.
45. Sundqvist, A., Liu, G., Mirsaliotis, A. and Xirodimas, D.P. (2009) Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep., 10, 1132-1139.
46. Mahata, B., Sundqvist, A. and Xirodimas, D.P. (2011) Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Oncogene, 31, 3060-3071.
47. Wan, F., Weaver, A., Gao, X., Bern, M., Hardwidge, P.R. and Lenardo, M.J. (2011) IKKbeta phosphorylation regulates RPS3 nuclear translocation and NF-kappaB function during infection with Escherichia coli strain O157:H7. Nat. Immunol., 12, 335-343.
48. Wu, Q., Gou, Y., Wang, Q., Jin, H., Cui, L., Zhang, Y., He, L., Wang, J., Nie, Y., Shi, Y. et al. (2011) Downregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines. PLoS One, 6, e26401.
49. Onel, K. and Cordon-Cardo, C. (2004) MDM2 and prognosis. Mol. Cancer Res., 2, 1-8.
50. Ooi, M.G., Hayden, P.J., Kotoula, V., McMillin, D.W., Charalambous, E., Daskalaki, E., Raje, N.S., Munshi, N.C., Chauhan, D., Hideshima, T. et al. (2009) Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib. Clin. Cancer Res., 15, 7153-7160.
51. Azmi, A.S., Beck, F.W., Sarkar, F.H. and Mohammad, R.M. (2011) Network perspectives on HDM2 inhibitor chemotherapy combinations. Curr. Pharm. Des., 17, 640-652.
52. Patel, S. and Player, M.R. (2008) Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer. Expert Opin. Investig. Drugs, 17, 1865-1882.